These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 17298437
1. A metabolomics perspective of human brain tumours. Griffin JL, Kauppinen RA. FEBS J; 2007 Mar; 274(5):1132-9. PubMed ID: 17298437 [Abstract] [Full Text] [Related]
2. Tumour metabolomics in animal models of human cancer. Griffin JL, Kauppinen RA. J Proteome Res; 2007 Feb; 6(2):498-505. PubMed ID: 17269706 [Abstract] [Full Text] [Related]
3. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). Chan EC, Koh PK, Mal M, Cheah PY, Eu KW, Backshall A, Cavill R, Nicholson JK, Keun HC. J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642 [Abstract] [Full Text] [Related]
4. New insights into cardiovascular and lipid metabolomics. Giovane A, Balestrieri A, Napoli C. J Cell Biochem; 2008 Oct 15; 105(3):648-54. PubMed ID: 18729082 [Abstract] [Full Text] [Related]
9. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI. Fayed N, Dávila J, Medrano J, Olmos S. Eur J Radiol; 2008 Sep 15; 67(3):427-33. PubMed ID: 18442889 [Abstract] [Full Text] [Related]
10. Combining nuclear magnetic resonance spectroscopy and mass spectrometry in biomarker discovery. Gowda GA, Ijare OB, Shanaiah N, Bezabeh T. Biomark Med; 2009 Jun 15; 3(3):307-22. PubMed ID: 20477478 [Abstract] [Full Text] [Related]
12. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors. Qi ZH, Li CF, Li ZF, Zhang K, Wang Q, Yu DX. Chin Med J (Engl); 2009 Jan 05; 122(1):39-43. PubMed ID: 19187615 [Abstract] [Full Text] [Related]
13. Spectroscopic magnetic resonance imaging of the brain: voxel localisation and tissue segmentation in the follow up of brain tumour. Poloni G, Bastianello S, Vultaggio A, Pozzi S, Maccabelli G, Germani G, Chiarati P, Pichiecchio A. Funct Neurol; 2008 Jan 05; 23(4):207-13. PubMed ID: 19331784 [Abstract] [Full Text] [Related]
14. In vivo magnetic resonance spectroscopy of gynaecological tumours at 3.0 Tesla. Booth SJ, Pickles MD, Turnbull LW. BJOG; 2009 Jan 05; 116(2):300-3. PubMed ID: 19076962 [Abstract] [Full Text] [Related]
15. Quality control of herbal material and phytopharmaceuticals with MS and NMR based metabolic fingerprinting. van der Kooy F, Maltese F, Choi YH, Kim HK, Verpoorte R. Planta Med; 2009 Jun 05; 75(7):763-75. PubMed ID: 19288400 [Abstract] [Full Text] [Related]
16. Linear discriminant analysis of brain tumour (1)H MR spectra: a comparison of classification using whole spectra versus metabolite quantification. Opstad KS, Ladroue C, Bell BA, Griffiths JR, Howe FA. NMR Biomed; 2007 Dec 05; 20(8):763-70. PubMed ID: 17326043 [Abstract] [Full Text] [Related]